CanBas Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY86.49 |
Market Cap |
JPY5.99 B |
Shares Outstanding |
6.83 M |
Public Float |
5.54 M |
Address |
2-2-1 Otemachi Numazu Shizuoka 410 Japan |
Employees | - |
Website | http://www.canbas.co.jp |
Updated | 07/08/2019 |
CanBas Co., Ltd. engages in pharmaceutical business. It focuses on the research and development of anti-cancer agent, drugs, and technologies which has minor impact on normal cell. Its technologies include drugs for the G2 check point and a screening system to find selective abrogates of the G2 check point. |